Composition:
Ferric Carboxy Maltose 500mg Injection
CKD patients often experience anaemia due to various factors including decreased production of erythropoietin by the kidneys and reduced red blood cell lifespan, blood loss from haemodialysis or gastrointestinal bleeding, and inadequate dietary intake of iron. In CKD patients, iron replacement therapy is often necessary to support erythropoiesis and improve haemoglobin levels, which can enhance patient well-being and quality of life.
*To be consumed as directed by physician.
